By tduggan on December 2, 2016
Researchers found no evidence to suggest that exposure to the antidepressants ‘selective serotonin reuptake inhibitors’ were associated with a delay in MS disability accumulation or progression.
Permalink | No Comments
Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia